Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Quanta Therapeutics
Quanta Therapeutics

Quanta Therapeutics

Series D

Quanta, founded in 2018, is a San Francisco-based biotech firm specializing in novel cancer therapeutics.

HQ
San Francisco, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees

Quanta Therapeutics, founded in 2018 and based in San Francisco, CA, is a biotechnology company focused on developing novel cancer therapeutics. The company's core mission is to uncover and develop allosteric modulators that target driver oncogenes, specifically RAS mutations, which are implicated in nearly one-quarter of all cancers. Quanta's innovative approach aims to create best-in-class allosteric inhibitors for difficult-to-treat cancers, including pancreatic, colorectal, lung, and endometrial cancers.

Quanta Therapeutics has attracted notable investors and industry leaders due to its groundbreaking work in KRAS therapy. The company’s key achievements include the development of allosteric small molecules targeting previously undruggable RAS mutations such as KRAS G12D and KRAS G12V. By focusing on these challenging targets, Quanta aims to significantly impact the treatment landscape for various aggressive cancers, potentially improving outcomes for many patients worldwide.

Quanta Therapeutics - Similar Companies

Kumquat Biosciences logo

Kumquat Biosciences

Dual Therapeutics logo

Dual Therapeutics

Boundless Bio logo

Boundless Bio

A2 Biotherapeutics logo

A2 Biotherapeutics

a2bio.com

Starton Therapeutics logo

Starton Therapeutics

Grannus Therapeutics logo

Grannus Therapeutics

HotSpot Therapeutics logo

HotSpot Therapeutics

hotspotthera.com

Kronos Bio logo

Kronos Bio

Star Therapeutics logo

Star Therapeutics

Peloton Therapeutics logo

Peloton Therapeutics

Ostentus Therapeutics logo

Ostentus Therapeutics

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

QurAlis logo

QurAlis

LTZ Therapeutics logo

LTZ Therapeutics

Indapta Therapeutics logo

Indapta Therapeutics

indapta.com

Quanta Therapeutics - Quick Facts

Who are Quanta Therapeutics' competitors?

Companies similar to Quanta Therapeutics include Kumquat Biosciences, Dual Therapeutics, Boundless Bio and A2 Biotherapeutics.

When was Quanta Therapeutics founded?

Quanta Therapeutics was founded in 2018.

Where is Quanta Therapeutics' headquarters located?

Quanta Therapeutics' headquarters is located in San Francisco, CA, US.

When was Quanta Therapeutics' last funding round?

Quanta Therapeutics' most recent funding round was for $50.7M (USD) in May 2023.

How much has Quanta Therapeutics raised to-date?

As of May 22, 2023, Quanta Therapeutics has raised a total of $140.7M (USD).

How many employees does Quanta Therapeutics have?

Quanta Therapeutics has 28 employees as of Feb 5, 2024.

Quanta Therapeutics - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified